Patient‐reported outcome ( PRO ) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments
Open Access
- 30 May 2017
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 120 (4) , 468-481
Abstract
To critically review conceptual frameworks for available patient‐reported outcome ( PRO ) questionnaires in men having radical prostatectomy ( RP ), psychometrically evaluate each questionnaire, and identify whether each is appropriate for use at the level of the individual patient. We searched PubMed, the Reports and Publications database of the University of Oxford Patient‐Reported Outcomes Measurement Group and the website of the International Consortium for Health Outcomes Measurement ( ICHOM ) for psychometric reviews of prostate cancer‐specific PRO questionnaires. From these we identified relevant questionnaires and critically appraised the conceptual content, guided by the Wilson and Cleary framework and psychometric properties, using well established criteria. The searches found four reviews and one recommendation paper. We identified seven prostate cancer‐specific PRO s: the Expanded Prostate Cancer Index Composite‐26 (EPIC‐26), Expanded Prostate Cancer Index Composite‐50 (EPIC‐50), University of California‐Los Angeles Prostate Cancer Index ( UCLA ‐ PCI ), Functional Assessment of Cancer Therapy ‐ Prostate Cancer Subscale (FACT‐P PCS), European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire – prostate specific 25‐item ( EORTC QLQ ‐ PR 25), Prostate Cancer – Quality of Life ( PC ‐QoL), and Symptom Tracking and Reporting ( STAR ). Six out of seven measures purported to measure health‐related quality of life ( HRQL ), but items focused strongly on urinary and sexual symptoms/functioning. The remaining questionnaire ( STAR ) claimed to assess functional recovery after RP . The psychometric evidence for these questionnaires was incomplete and variable in quality; none had evidence that they were appropriate for use with individual patients. Several questionnaires provide the basis of measures of urinary and/or sexual symptoms/functioning. Further work should explore other aspects of HRQL that are important for men having RP . Further psychometric work is also needed to determine whether they can be used at the individual level.Keywords
Funding Information
- Prostate Cancer UK (250-45)
This publication has 31 references indexed in Scilit:
- Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: a cross-sectional surveyBMJ Open, 2013
- Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklistQuality of Life Research, 2011
- Understanding Rasch and Item Response Theory Models: Applications to the Estimation and Validation of Interval Latent Trait Measures from Responses to Rating Scale QuestionnairesOphthalmic Epidemiology, 2011
- Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer SurvivorsUrology, 2010
- An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancerEuropean Journal of Cancer, 2008
- Living after radical prostatectomy for localized prostate cancer. A qualitative analysis of patient narrativesActa Oncologica, 2005
- The UCLA Prostate Cancer IndexMedical Care, 1998
- Developing and evaluating cross-cultural instruments from minimum requirements to optimal modelsQuality of Life Research, 1993
- Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL)Quality of Life Research, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993